Targeting Microenvironment and Cellular Immunity in Sarcomas Weekly trabectedin combined with Metronomic Cyclophosphamide in Patients with Advanced Pretreated Soft-tissue Sarcomas. A Phase I/II study from the French Sarcoma Group.
Phase of Trial: Phase I/II
Latest Information Update: 23 Jun 2016
At a glance
- Drugs Trabectedin (Primary) ; Cyclophosphamide
- Indications Soft tissue sarcoma
- Focus Adverse reactions
- Acronyms TARMIC
- 15 Jun 2016 Planned End Date changed from 19 Oct 2018 to 1 Dec 2018.
- 15 Jun 2016 Planned primary completion date changed to 1 Jun 2018.
- 15 Mar 2016 New trial record